CLAIM CARD
`fact_id=188542` (`A_core`) — T-cytotoxic senescent cell percentages decreased significantly by -10.96%±12.59 (p=0.0004) post-HBOT. doi=10.18632/aging.202188
Evidence grade: exploratory
Contradiction status: none
Publication: 966edf82-6b1e-4214-8625-15d80ed50795
Provenance: Derivation Web chain
Citation Support
source_1Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells : a prospective trialsource_2Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trialssource_3Meta-Analysis on the Efficacy and Safety of Hyperbaric Oxygen as Adjunctive Therapy for Vascular Dementiasource_4Potential markers of healing from near infrared spectroscopy imaging of venous leg ulcer. A randomized controlled clinical trial comparing conventional with hyperbaric oxygen treatmentsource_5Hyperbaric oxygen therapy for nonischemic diabetic ulcers: A systematic review